November 20, 2014
UC San Diego Health System is a world leader in chronic thromboembolic pulmonary hypertension (CTEPH), and now with a $7.6 million grant, has helped launch the first national CTEPH registry to improve best practices and patient care.
January 6, 2023
UC San Diego researchers suggest that rising levels of manmade chemicals, accumulating in marine plankton, might be used to monitor the impact of human activity on ecosystem health and perhaps study links between ocean pollution and land-based rates of childhood and adult chronic illnesses.
June 13, 2018
Neglected tropical diseases are a group of chronic and disabling parasitic infections that primarily affect poor and underserved communities. These diseases affect more than 1 billion people globally, yet are rarely the target of new drug discovery efforts. Leveraging its strengths in molecular biology, clinical research and pharmaceutical sciences, the…
August 2, 2018
UC San Diego and UCLA led the University of California system during the 2017 fiscal year in the number of commercial startups based on campus inventions, according to a report released this week by the University of California’s Office of the President.
November 24, 2014
…and nonalcoholic fatty liver disease (NAFLD) are two emerging health problems related to the epidemic of childhood obesity. In a recent study, researchers at University of California, San Diego School of Medicine sought to determine the prevalence of high blood pressure in children with NAFLD, which places them at risk…
August 24, 2011
Inflammatory bowel disease (IBD), which affects more than 1 million patients in North America, results from an uncontrolled immune response triggered by environmental factors, such as bacteria, in people genetically predisposed to the disorder. Ulcerative colitis, or inflammation of the lining of the colon, is one such condition.
July 25, 2018
In a study published online July 25 in the journal Nature, University of California San Diego School of Medicine researchers identified a signaling pathway that activates the NLRP3 inflammasome implicated in several severe chronic inflammatory disorders.
July 29, 2015
Researchers at the University of California, San Diego School of Medicine have demonstrated a direct connection between two signaling proteins and liver fibrosis, a scarring process underlying chronic liver disease, the 12th leading cause of death in the United States.
October 3, 2016
…use dogs as animal models for humans with this disease. The study is published October 3 in Nature Microbiology.
April 11, 2019
Treatment with a choline kinase inhibitor prompts immune cells to clear away damaged mitochondria, thus reducing NLRP3 inflammasome activation and preventing inflammation
